New Biomarker Test Helps Avoid Biopsy When mpMRI Isn’t Available
What happens when cutting-edge MRI isn’t within reach for prostate cancer screening? A simple blood test now promises to cut needless biopsies and healthcare costs. The Stockholm3 test combines genetic, protein, and clinical markers to fine-tune prostate cancer detection—potentially sparing men invasive procedures. keep reading
